Close Menu

NEW YORK (GenomeWeb) – Roka Bioscience reported on Friday that its second quarter revenues rose 20 percent year over year thanks to an increase in the number of Atlas molecular pathogen detection instruments placed with customers.

For the three months ended June 30, the firm reported total revenues of $1.8 million, up from $1.5 million a year ago. As of June 30, the company had placed 46 instruments with customers under commercial agreements, up from 44 instruments as of March 31.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.